Related Experiment Video

Updated: Jun 14, 2026

Electromagnetic Source Imaging in Presurgical Evaluation of Children with Drug-Resistant Epilepsy
09:57

Electromagnetic Source Imaging in Presurgical Evaluation of Children with Drug-Resistant Epilepsy

Published on: September 20, 2024

Efficacy and tolerability of levetiracetam in children with epilepsy

Jiahui Li1, Nong Xiao, Siyuan Chen

  • 1Department of Rehabilitation Center, Children's Hospital of Chongqing Medical University, China.

Brain & Development
|April 3, 2010
PubMed

Insights

Levetiracetam (Lev) demonstrated significant efficacy and good tolerability in pediatric epilepsy patients. Most children achieved seizure freedom or reduction, with a high retention rate indicating its safety and effectiveness.

Area of Science:

  • Pediatric Neurology
  • Clinical Pharmacology

Background:

  • Epilepsy affects a significant number of children worldwide.
  • Levetiracetam is an antiepileptic drug with a broad spectrum of action.
  • Assessing its use in pediatric populations is crucial for treatment optimization.

Purpose of the Study:

  • To evaluate the efficacy of levetiracetam in treating pediatric epilepsy.
  • To assess the tolerability and safety profile of levetiracetam in children.
  • To determine the retention rate and reasons for withdrawal in this cohort.

Main Methods:

  • An open-label, prospective, single-arm, non-interventional study.
  • 120 pediatric patients (≤14 years) with epilepsy were enrolled.
  • Levetiracetam dosage was initiated at 10mg/kg/day, titrated up to a maximum of 60mg/kg/day, with seizure control and side effects monitored.

Main Results:

  • 64.8% of patients achieved seizure freedom, and 83.0% experienced ≥50% seizure reduction.
  • Common side effects included somnolence and nervousness, with an overall incidence rate of 47.5%.
  • The one-year retention rate was 73.3%, with poor efficacy being the primary reason for withdrawal.

Conclusions:

  • Levetiracetam appears to be a safe and effective antiepileptic drug for various seizure types in children.
  • The drug shows a favorable efficacy and tolerability profile in pediatric epilepsy management.
  • Further research can explore long-term outcomes and specific epilepsy syndromes in children treated with levetiracetam.
Abstract

More Related Videos

A Model for Epilepsy of Infectious Etiology using Theiler's Murine Encephalomyelitis Virus05:33

A Model for Epilepsy of Infectious Etiology using Theiler's Murine Encephalomyelitis Virus

Published on: June 23, 2022

Related Concept Videos

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...